ARID1A缺失通过表观遗传调控肝脏脂肪合成与脂肪酸氧化驱动小鼠非酒精性脂肪性肝炎
研究探索染色质重塑因子ARID1A在非酒精性脂肪性肝炎(NASH)中的作用,发现肝脏特异性敲除Arid1a可导致小鼠年龄依赖性脂肪肝,转录组显示脂肪合成基因上调、脂肪酸氧化基因下调,ARID1A直接结合这些基因启动子;Arid1a敲除小鼠对高脂饮食诱导的脂肪变性和纤维化更敏感,联合Pten缺失加速脂肪肝进展,使用SREBP抑制剂CAT-2003可改善脂肪肝进展标志物。
要点
- 肝脏特异性Arid1a敲除导致小鼠年龄依赖性脂肪肝,脂肪合成上调、脂肪酸氧化下调。
- ARID1A直接结合多个差异调控基因的启动子,发挥表观遗传调控作用。
- Arid1a/Pten双敲除小鼠脂肪肝进展加速,CAT-2003可改善脂肪肝进展标志物。
核心结论
- ARID1A参与肝脏脂质稳态的表观遗传调控,其抑制促进脂肪肝发病。
- 联合Arid1a和Pten缺失加速脂肪肝疾病进展,是研究NASH治疗策略的有用小鼠模型。
研究设计与样本
- 研究使用肝脏特异性Arid1a敲除小鼠(Arid1a LKO)及Arid1a/Pten双敲除小鼠模型,进行转录组分析。
主要发现
- Arid1a LKO小鼠出现年龄依赖性脂肪肝,转录组显示脂肪合成基因上调、脂肪酸氧化基因下调。
- ARID1A直接结合许多差异调控基因的启动子。
- Arid1a LKO小鼠对高脂饮食诱导的肝脏脂肪变性和纤维化更易感。
- 联合Pten缺失协同驱动脂肪肝进展。
- 使用CAT-2003(一种强效SREBP抑制剂)抑制脂肪合成,可改善Arid1a/Pten双敲除模型中脂肪肝进展标志物。
局限性
- 原文未报告局限性
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Nonalcoholic steatohepatitis (NASH) is a rapidly growing cause of chronic liver damage, cirrhosis, and hepatocellular carcinoma. How fatty liver pathogenesis is subject to epigenetic regulation is unknown. We hypothesized that chromatin remodeling is important for the pathogenesis of fatty liver disease. AT-rich interactive domain-containing protein 1A (ARID1A), a DNA-binding component of the SWItch/sucrose nonfermentable adenosine triphosphate-dependent chromatin-remodeling complex, contributes to nucleosome repositioning and access by transcriptional regulators. Liver-specific deletion of Arid1a (Arid1a liver knockout [LKO]) caused the development of age-dependent fatty liver disease in mice. Transcriptome analysis revealed up-regulation of lipogenesis and down-regulation of fatty acid oxidation genes. As evidence of direct regulation, ARID1A demonstrated direct binding to the promoters of many of these differentially regulated genes. Additionally, Arid1a LKO mice were more susceptible to high-fat diet-induced liver steatosis and fibrosis. We deleted Pten in combination with Arid1a to synergistically drive fatty liver progression. Inhibition of lipogenesis using CAT-2003, a potent sterol regulatory element-binding protein inhibitor, mediated improvements in markers of fatty liver disease progression in this Arid1a/Pten double knockout model. Conclusion: ARID1A plays a role in the epigenetic regulation of hepatic lipid homeostasis, and its suppression contributes to fatty liver pathogenesis. Combined Arid1a and Pten deletion shows accelerated fatty liver disease progression and is a useful mouse model for studying therapeutic strategies for NASH.
引用
- Moore A, Wu L, Chuang JC, et al. Arid1a Loss Drives Nonalcoholic Steatohepatitis in Mice Through Epigenetic Dysregulation of Hepatic Lipogenesis and Fatty Acid Oxidation. Hepatology. 2019. PMID: 30584660. doi:10.1002/hep.30487
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。